NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE654.3519.95 (+3.14 %)
PREV CLOSE ( ) 634.40
OPEN PRICE ( ) 640.70
BID PRICE (QTY) 654.35 (42)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 418232
TODAY'S LOW / HIGH ( )640.70 662.50
52 WK LOW / HIGH ( )527.05 808.95
NSE655.9020.6 (+3.24 %)
PREV CLOSE( ) 635.30
OPEN PRICE ( ) 642.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 655.90 (3950)
VOLUME 6687761
TODAY'S LOW / HIGH( ) 640.80 662.90
52 WK LOW / HIGH ( )527 809.45
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
 Listing : BSE, NSE, MCX
NEWS
10Aug Aurobindo Pharma reports 12% fall in Q
Aurobindo Pharma has reported results for first quarter ended June 30, 2..
07Aug Aurobindo Pharma informs about newspap
Aurobindo Pharma has informed about paper cuttings of the notice publish..
30Jul Aurobindo Pharma receives USFDA approv
Aurobindo Pharma has received final approval from the US Food & Drug..
30Jul Aurobindo Pharma shines on receiving U
Aurobindo Pharma is currently trading at Rs. 603.55, up by 12.35 points..
30Jul Aurobindo Pharma informs about press r
Aurobindo Pharma has informed about Press Release issued by the Company..
MORE
Financials
Rs. in Millions
QTR Jun 18 ANNUAL 18
Net Profit2251.218127.7
Gross Profit 2820.5 23429.4
Operating Profit 3995.827506.6
Net Sales 25588.2103031.5
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7782.25 (2.87%)
M.Cap (Rs. in Cr)16536.74
Astrazeneca Pharma I (BSE)
 1840.75 (7.63%)
M.Cap (Rs. in Cr)4601.88
Torrent Pharma (BSE)
 1766.70 (3.98%)
M.Cap (Rs. in Cr)29896.58
Alkem Laboratories (BSE)
 2091.95 (2.57%)
M.Cap (Rs. in Cr)25012.40
Coral Laboratories (BSE)
 517.25 (8.67%)
M.Cap (Rs. in Cr)184.79
MORE
Shareholding Pattern
PROMOTERS 51.87%
MUTUAL FUNDS/UTI 15.23%
NON-INSTITUTION 14.53%
FI/BANKS/INSURANCE 0.59%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| DISCLAIMER| DISCLOSURE| SEBI| FMC| NSE| BSE| MCX
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.